Clinical trial Recruiting at 1 site Interventional Ages 18 to 85

Melanin-Adjusted Blood Oxygen Sensor in ICU Patients

Official title: Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings: Improving the Accuracy in Critical Conditions for Patients of Color

Run by University of North Carolina, Chapel Hill · NCT07799454 · Data updated 2026-11-12

This study tests a new pulse oximeter that adjusts for skin pigment to see if it gives accurate oxygen readings in ICU patients.

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedJanuary 6, 2026
Main results expectedDecember 15, 2026
Study endsDecember 15, 2026
Registry record updatedSeptember 2, 2026
Trial IDNCT07799454 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to 85 admitted to UNC Medical ICU or Cardiovascular and Thoracic ICU who require at least two arterial blood gas measurements within 24 hours.

Probably not a fit

Patients with active skin disorders, tattoos on sensor sites, or conditions affecting melanin outside the included spectrum may not benefit from the device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study evaluates the accuracy of a novel pulse oximeter, MABOS, across adults with varying skin tones who require frequent arterial blood gas measurements in intensive care settings. Participants will have skin tone measured with a spectrophotometer and will wear the MABOS device on one finger of each hand, plus a variant on an additional finger and wrist. Data from all devices will be collected continuously for up to 24 hours or until four arterial blood gas tests are obtained. Enrollment targets up to 120 adults admitted to UNC Hospitals’ ICUs. English proficiency is required for participants or their legally authorized representatives.

Why it matters

Potential benefit: If successful, patients may receive more accurate oxygen readings across skin tones, potentially improving critical-care decisions.

How similar studies have gone: Prior work with alternative pulse oximeter technologies has shown variable accuracy across skin tones; this approach aims to address that gap, with mixed prior results in similar devices.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ranges from 18 to 85 years.
* Individuals admitted to one of UNC Hospital's intensive care units (Medical Intensive Care Unit or Cardiovascular and Thoracic Intensive Care Unit).
* Individuals with a medical condition necessitating a minimum of two arterial blood gas measurements within a 24-hour period.
* Participant, or Legally Authorized Representative (LAR) must be able to read, write, and speak English fluently.

Exclusion Criteria:

* History of active (clinically significant) skin disorders that make skin vulnerable to contact with conventional electronic devices.
* History of allergic response to silicones, adhesives (such as 3M Tegaderm), or acetone.
* Broken, damaged or irritated skin or rashes near the sensor application sites.
* Presence of tattoos on the fingers, hands, or forearms.
* History of a genetic condition or skin disorder that variably impacts the amount of melanin pigmentation (e.g., Vitiligo).
* Pregnant or lactating individuals
* Individuals given methylene blue within the last 24 hours or Hydroxocobalamin within the last 2 weeks.
* Individuals experiencing carbon monoxide poisoning.
* History of conditions that may affect ABG readings (e.g., lipemic specimens).
* History of hematological conditions affecting red blood cell morphology (e.g., sickle cell disease)
* Patients on Venoarterial extracorporeal membrane oxygenation (VA-ECMO), durable left ventricular assist device (LVAD), or Impella.

Where it's running

  • University of North Carolina at Chapel Hill Hospitals
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Wubin Bai, Ph.D. — University of North Carolina, Chapel Hill
  • Study coordinator: Arjun Putcha, M.S.
  • Email: arjun22@live.unc.edu
  • Phone: 704-954-4398

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.